Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues
- 3 February 2021
- book chapter
- Published by Springer Nature
- Vol. 1297, 43-64
Abstract
The potential use of cannabinoids for therapeutic purposes is at the forefront of cannabinoid research which aims to develop innovative strategies to prevent, manage and treat a broad spectrum of human diseases. This chapter briefly reviews the pivotal role of the endocannabinoid system in modulating the central nervous system and its roles on neurodegenerative diseases and brain disorders. Ligand-induced modulation of cannabinoid 1 and 2 receptors to modulate immune response, decrease neurodegeneration and pain are aspects that are also discussed. Keywords Cannabinoid receptors Endocannabinoid system Non-cannabinoid receptors CB1R CB2R TRVP1 Endogenous ligands Cannabinoid ligands Neurodegenerative diseases CNS disordersKeywords
This publication has 204 references indexed in Scilit:
- Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cellsCell Death & Disease, 2013
- Brain cannabinoid CB2 receptors modulate cocaine's actions in miceNature Neuroscience, 2011
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppressionImmunobiology, 2010
- Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbensSynapse, 2010
- Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomasGlia, 2010
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's diseaseGlia, 2008
- Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: Quantification of migration by a novel near‐infrared methodGlia, 2008
- Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsyNeuroscience Letters, 2007
- Adult epilepsyThe Lancet, 2006